Skip to main content
. 2013 Dec 24;8(4):371–379. doi: 10.5009/gnl.2014.8.4.371

Table 6.

Gastrointestinal Symptom Severity in the Misoprostol and Rebamipide Groups

Gastrointestinal symptoms Visit Misoprostol Rebamipide p-value*


No. Mean±SD No. Mean±SD
ITT (LOCF) Baseline 237 0.33±0.59 242 0.24±0.54 0.0002
4 wk 218 0.80±1.14 236 0.44±0.92
8 wk 218 0.67±1.19 236 0.36±0.78
12 wk 218 0.67±1.24 236 0.44±1.05

ITT, intention to treat; LOCF, last observation carried forward.

*

Repeated-measures analysis of variance.